I Asked AI to Count My Carbs 27,000 Times. It Couldn’t Give Me the Same Answer Twice.
Ask ChatGPT to estimate the carbs in your lunch. Now ask it again. And again. Five hundred times. You’d expect the same answer each time. […]
Diabetes
100% Insulin Independence: Why Eledon’s Breakthrough is a Pillar, Not a Cure
Eledon Pharmaceuticals recently achieved 100% insulin independence in an early-phase islet transplant trial using its anti-CD40L drug, tegoprubart. It’s a massive step forward in transplant immunology that avoids the toxicity of standard drugs. But why isn’t it a cure yet, and how does it fit into the actual blueprint of a functional cure?
Explore a Decade of Diabetes Insights with Diabettech AI
After 10+ years of documenting the diabetes landscape, Diabettech is launching diabettech.ai—a custom research tool designed to help you navigate a decade’s worth of articles and reports. Powered by an LLM interface, this tool allows you to “interrogate” the site’s data to find specific answers on everything from cures to n=1 observations.
Key highlights of the beta launch:
Targeted Accuracy: Built to stick strictly to Diabettech articles and comments to minimize “hallucinations.”
Research-Focused: Optimized as a precision tool rather than a standard chatbot to provide relevant article links.
Sustainable Design: Privately funded and optimized for efficiency to manage resource costs and query speeds.
Ready to dive into the archives? Visit diabettech.ai to start your research and share your feedback on the beta experience.
Now We Know What a Type 1 Cure Could Look Like
The Type 1 cure is no longer theoretical. Human data now points to a blueprint: working cells, immune evasion, and durable immune modulation.
What If Type 1 Diabetes Was Treatable — If You Found It Early Enough?
For most of its history, type 1 diabetes (T1D) has been diagnosed late. By the time symptoms appear, the autoimmune destruction of pancreatic beta cells […]
A “twiist” of Fate: Why Sequel is Moving Beyond Tidepool to Embrace Diabeloop
For those in the “We Are Not Waiting” camp, the Sequel twiist pump was supposed to be the commercial homecoming for Tidepool Loop. It promised […]
Introducing The Daily Bolus: Parsing the Signal from the Noise
Date: January 13, 2026 If you’ve been following Diabettech for a while, you know that my focus has always been on the deep dives—the “Nine […]
ChatGPT Health: Promise, Practicality, and the Reality for People with Diabetes
Artificial intelligence has been hovering around diabetes care for a while now, usually wrapped in glossy demos and ambitious claims. Carb-counting apps that “just work”. […]
A pump update and then… Something changed!
I’d been using an Accuchek Insight for getting on for five years, starting in 2020 with a hand me down, then obtaining one of the […]
The Nine Sensor Samba: How do the Consensus Error Grids stack up?
Taking the evaluation of the nine sensors a step further with Consensus Error Grids and looking at the price performance of the sensors.